Fauci Reflects on His Remarkable Career in Letvin Lecture
Anthony S. Fauci, MD, visited Duke at the invitation of Bart Haynes, MD, Frederic M. Hanes Distinguished Professor of Medicine and director of the Duke Human Vaccine Institute (DHVI). He took the audience on a journey though time spanning his 58-year medical career.
COVID-19 Pandemic Alters View that Doctors are Obligated to Provide Care
The unique circumstances arising from the COVID-19 pandemic altered a long-held convention that doctors provide care regardless of personal risk.
Lefkowitz Lecture: Progress in Solving the Mystery of Long COVID
Long COVID appears to be not one disease but different collections of symptoms all precipitated by an acute COVID infection, said Akiko Iwasaki, PhD, during the annual Robert J. Lefkowitz, MD, Distinguished Lecture.
Duke-NUS Scientists Discover Potential Nasal COVID-19 Vaccine Candidate that Offers Better and Longer Protection
Novel findings from a preclinical head-to-head comparison show that administering a COVID-19 vaccine as a nasal spray, rather than subcutaneous injection, enhances the body’s long-term immune memory, thereby increasing the vaccine’s overall effectiveness.
Probiotics Reduce COVID Symptoms and Delay Disease Among Unvaccinated
Probiotics, specifically lactobacillus, demonstrated significant ability to delay a COVID infection and reduce symptoms among a group of unvaccinated people who had been in contact with someone in their household diagnosed with COVID.
Mary E. Klotman's Friday Message & Conversation with Kanecia Zimmerman, MD, PhD, MPH
Mary Klotman, MD, Talks with Kanecia Zimmerman, MD, PhD, MPH, who is Duke's principal investigator for the Clinical Trials Data Coordinating Center for research on Long COVID.
Single Vaccine Protects Against Three Deadly Strains of Coronavirus
A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.
Hispanic Heritage and Language Influence COVID-19 Testing and Vaccination
From Dominican and Puerto Rican to Mexican heritage, the choices made in confronting the virus are as diverse as the cultures represented in a new national study of COVID-19 patterns led by Duke University School of Medicine.
Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
Fluvoxamine, an antidepressant, is one of four FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study.
What to Expect From COVID This Fall
Speaking to media in a virtual briefing, infectious disease specialist Dr. Cameron Wolfe and David Montefiori, Ph.D., director of the Duke Human Vaccine Institute, said booster shots continue to be effective for those Americans who routinely get them.